Epstein Secrets

/20/2015 2:33:27 PM To: Jeffrey Epstein feevacation@ mail coml CC: Daniel Sabba I I: Ariane Dw Subject: BUB rCi Classification: Confidential Paul Morris Jeffrey — Rich suggested we reach out RE: your Biogen position. BUJ is up over 15% from last week to $475.08 currently. Note that you're long 2,09

coml CC: Daniel Sabba I I: Ariane Dw Subject: BUB rCi Classification: Confidential Paul Morris Jeffrey — Rich suggested we reach out RE: your Biogen position. BUJ is up over 15% from last week to $475.08 currently. Note that you're long 2,095 shares, purchased on 2/14/2012 @ $119.5489 (unrealize

From: Tazia Smith ii Sent: 4/23/2014 11:54:05 AM To: [email protected] CC: ; Paul Morris Vahe Stepanian [ Subject: WY and Biotech [CI Attachments: 182298_20140422_20140423_1.pdf Classification: Confidential Jeffrey - _] Nav Gupta

ial Jeffrey - _] Nav Gupta Vinit Sahni Just posting you on your biotech basket - earnings a positive catalyst reversing that downtrend in Gilead. Biogen reported this morning (bottom line miss, top-line beat), stock has come in from pre-market highs of $310, now -$303 (3-day chart below). Just a re

From: Tazia Smith Sent: 4/23/2014 11:54:04 AM To: [email protected] CC: • Paul Morris I; Nav Gupta ; Vinit Sahni J; Vah Stepanian I Subject: WY and Biotech (C) Attachments: pic24428.gif; pic23103.gif; pic27254.gif; pic21295.gif;

Classification: Confidential Jeffrey - Just posting you on your biotech basket - earnings a positive catalyst reversing that downtrend in Gilead. Biogen reported this morning (bottom line miss, top-line beat), stock has come in from pre-market highs of 5310, now — $303 (3-day chart below). Just a re